A number of genetic alterations seen in CN-AML patients with possible prognostic relevance (DNMT3A, IDH1/2, TET2) are not considered here, and the correlation of TIGAR expression and outcome may not be independent of other variables in CN-AML. The gene discussed is DNMT3A; the disease is acute myeloid leukemia.